Comparison of coagulation parameters for healthy subjects and behçet disease patients with and without vascular involvement

World Journal of Surgery

Volumn 24, Issue 12, 2000, Pages 1584-1588

  Şengül, Neriman ^a   Demirer, Seher ^a   Yerdel, M Ali ^a   Terzioǧlu, Gökay ^a   Akin, Bariş ^a   Gürler, Aysel ^a   Tüzüner, Altan ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; FIBRINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBOPLASTIN;

ADOLESCENT; ADULT; ARTICLE; BEHCET DISEASE; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBOSIS; VASCULAR DISEASE;

ADOLESCENT; ADULT; BEHCET SYNDROME; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THROMBOSIS; TIME FACTORS;

EID: 0034524221     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002680010282     Document Type: Article

References (37)

1. Behçet disease (Behçet syndrome)
2. Vasculitis in Behçet disease
3. Vascular involvement in Behçet's disease
4. Behçet-type vasculopathy in a patient without the diagnostic features of Behçet's disease
5. The prethrombotic/hypercoagulable state of Behçet's disease: Comment on the article by Golden et al.
6. Evaluation of peripheral vascular system disorders in vascular symptom-free Behçet's disease
7. Vascular manifestations in Behçet's disease
8. Behçet's disease in the etiology of Budd-Chiari disease
9. Large artery involvement in Behçet's disease
10. Surgical aspects of Behçet's disease
11. Rare rheumatic disorders: Behçet's disease
12. Impaired haemostatic kinetics and endothelial function in Behçet's disease
13. Behçet's disease
14. Superficial thrombophlebitis. II. Secondary hypercoagulable states
15. Coagulation and fibrinolytic activity in Behçet's disease
16. Experimental studies on venous thrombosis: Effect of coagulants, procoagulants and vessel contusion
17. Syndromes of thrombosis and hypercoagulability: Congenital and acquired causes of thrombosis
18. Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports
19. Evaluation or recurrent thrombosis and hypercoagulability
20. Thrombotic syndromes and autoimmune disease
21. Behçet syndrome associated with protein S deficiency
22. Extensive venous thrombosis in a case of Behçet's disease associated with heterozygous protein C deficiency
23. Protein S deficiency and antibodies to protein S in patients with Behçet's disease
24. Protein C and protein S activities in Behçet's disease as risk factors of thrombosis
25. Fibrinogen: An important risk factor for atherothrombotic diseases
26. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
27. Cardiovascular disease, fibrinogen and the acute phase response
28. Von Willebrand factor in Behçet's sydrome
29. Coagulation factor V gene mutation increases the risk of venous thrombosis in Behçet's disease
30. Vascular involvement in Behçet's disease: Arterial and venous and vessels of all sizes
31. Antibodies to endothelial cell in patients with Behçet's disease
32. Antibodies to endothelial cells in Behçet's disease: Cell-binding heterogeneity and association with clinical activity
33. Thrombosis and cardiovascular disease
34. Pathogenesis of venous thrombosis: A new insight
35. Activated protein C resistance caused by factor V Arg 506→gln mutation has no role in thrombotic manifestations of Behçet's disease
36. Activated protein C resistance in Behçet's disease
37. Defective fibrinolysis in Behçet's syndrome: Significance and possible mechanisms